Showing results (1601-1610 of 1,963) with videos related to

Sort By:
Pageof 197
Molecular Cancer Therapeutics|August 27, 2003
Gene-directed enzyme prodrug therapy for osteosarcoma: sensitization to CPT-11 in vitro and in vivo by adenoviral delivery of a gene encoding secreted carboxylesterase-2Dinja Oosterhoff, M Adhiambo Witlox, Victor W van Beusechem, et al.
European Journal of Cancer (Oxford, England : 1990)|July 8, 2020
Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancerMaarten J van der Doelen, Pedro Isaacsson Velho, Peter H J Slootbeek, et al.
Circulation Research|April 28, 2001
Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic miceB J van Vlijmen, G Gerritsen, A L Franken, et al.
Ophthalmology Science|September 11, 2025
Bile Acid Metabolism Changes in Patients with a CRB1-Associated Inherited Retinal DegenerationLude Moekotte, Joke H de Boer, Sanne Hiddingh, et al.
Molecular Pharmaceutics|September 17, 2019
Quantitative Translation of Microfluidic Transporter in Vitro Data to in Vivo Reveals Impaired Albumin-Facilitated Indoxyl Sulfate Secretion in Chronic Kidney DiseaseThomas K van der Made, Michele Fedecostante, Daniel Scotcher, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
Multi-centre prospective study on diagnosing subtypes of lung cancer by exhaled-breath analysisS Kort, M M Tiggeloven, M Brusse-Keizer, et al.
Frontiers in Immunology|January 20, 2022
Spatial and Temporal Heterogeneity of Tumor-Infiltrating Lymphocytes in Advanced Urothelial CancerSandra van Wilpe, Mark A J Gorris, Lieke L van der Woude, et al.
Nature Communications|December 22, 2011
Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potentialNigel M Stapleton, Jan Terje Andersen, Annette M Stemerding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2008
PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastomaJanine Stutterheim, Annemieke Gerritsen, Lily Zappeij-Kannegieter, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Selective targeting of oncogenic KRAS G12D using peptide nucleic acid oligomers attached to cell-penetrating peptidesJayati Mondal, Dennis Lam, Mary E Gerritsen, et al.
Pageof 197